AI Insights · Timothy · January 2023
Top 5 Health and Fitness Apps on iOS in Colombia Q4 2022
Discover the performance trends of the top 5 health and fitness apps on iOS in Colombia during Q4 2022, featuring insights on downloads, revenue, and active users.
Strava: Run, Bike, Hike
Strava: Run, Bike, Hike witnessed a dynamic performance in Q4 2022. Weekly revenue fluctuated, peaking at around $6K in late September and ending the quarter at approximately $4.8K. The app's weekly downloads showed a varied trend, starting at 818 and dipping to a low of 520 in mid-December before recovering to 707 by the end of the quarter. Weekly active users experienced a steady increase, starting at 21K and reaching 25.6K by the last week of December.
silBe by Silvy Araujo
silBe by Silvy Araujo had a notable quarter with significant variations in weekly revenue, which peaked at about $5.3K in late October. Downloads were relatively stable, with a notable increase to 385 by the end of December.
Zwift: Ride and Run
Zwift: Ride and Run showed a consistent pattern in weekly revenue, maintaining around $2K to $3K throughout the quarter. Weekly downloads remained low but steady, with a peak of 98 in mid-December. Active users fluctuated slightly, starting at 437 and ending the quarter at 382.
Flo Period & Pregnancy Tracker
Flo Period & Pregnancy Tracker experienced a steady increase in weekly revenue, reaching approximately $2.5K by the end of December. Downloads saw a significant rise, peaking at 3.9K in late November. Active users remained high, starting at 56.5K and ending the quarter at 55.6K.
Calm
Calm had a varied performance with its weekly revenue peaking at around $2.1K in early October. Downloads showed a steady trend, peaking at 299 in the last week of December. Active users saw a decline, starting at 15.4K and closing the quarter at 14.3K.
These insights, derived from Sensor Tower data, provide a detailed overview of the health and fitness app landscape in Colombia for Q4 2022. For more comprehensive insights, visit Sensor Tower.